Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer
Rigter, L.S., Loo, C.E., Linn, S.C., Sonke, G.S., van Werkhoven, E., Lips, E.H., Warnars, H.A., Doll, P.K., Bruining, A., Mandjes, I.A.M., Vrancken Peeters, M.J., Wesseling, J., Gilhuijs, K.G.A., Rodenhuis, S
DOI: https://doi.org/10.1038/bjc.2013.661
British Journal of Cancer 109 (12), p. 2965-2972